0001886659-21-000001.txt : 20211006 0001886659-21-000001.hdr.sgml : 20211006 20211006155016 ACCESSION NUMBER: 0001886659-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20211006 DATE AS OF CHANGE: 20211006 EFFECTIVENESS DATE: 20211006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NMB Therapeutics, Inc CENTRAL INDEX KEY: 0001886659 IRS NUMBER: 371751714 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-415938 FILM NUMBER: 211309752 BUSINESS ADDRESS: STREET 1: 395 WESTBURY BLVD CITY: HEMPSTEAD STATE: NY ZIP: 11550 BUSINESS PHONE: 6466448760 MAIL ADDRESS: STREET 1: 540 BRYANT AVE CITY: ROSLYN HARBOR STATE: NY ZIP: 11576 D 1 primary_doc.xml X0708 D LIVE 0001886659 NMB Therapeutics, Inc 395 WESTBURY BLVD HEMPSTEAD NY NEW YORK 11550 6466448760 FLORIDA None None Corporation true Murray Froikin 235 E 50th St, #57 New York NY NEW YORK 10022 Executive Officer CFO Daniel Fisher 36 Marlee road Pleasant Hill CA CALIFORNIA 94523 Executive Officer Director President Melvin Ehrlich 540 Bryant Ave Roslyn Harbor NY NEW YORK 11576 Executive Officer Director Chairman Biotechnology $1 - $1,000,000 06c false 2021-09-27 false true false 0 200000 60000 140000 ask Murray Froikin false 1 0 0 0 false NMB Therapeutics, Inc Murray Froikin Murray Froikin CFO 2021-10-06